10月9日晚间，利民控股集团股份有限公司(以下简称"利民股份（002734）")发布2025年前三季度业绩 预告。数据显示，公司前三季度预计实现归属于上市公司股东的净利润3.84亿元至3.94亿元，同比增长 649.71%至669.25%。 单季度业绩同样延续高增长态势。今年第三季度，利民股份预计实现归属于上市公司股东的净利润1.15 亿元至1.25亿元，同比增长490.85%至542.23%，持续承接上半年增长动能。 受业绩利好推动，截至10月10日上午收盘，利民股份股价报19.07元/股，上涨5.77%，总市值攀升至 84.69亿元。 对于业绩变动的原因，公告显示，由于公司主要产品销量和价格同比上涨、毛利率提升以及参股公司业 绩上涨带来投资收益增加所致。结合2025年上半年年报数据，利民股份核心业务涵盖农药、兽药两大领 域，其中农药业务毛利率达26.45%，同比提升8.71个百分点；兽药业务毛利率为21.66%，同比增长1.48 个百分点，两大板块盈利水平均实现稳步改善。 市场端，利民股份已在坦桑尼亚建立成熟的市场渠道，并于2024年成功拓展肯尼亚市场，进一步扩大非 洲区域覆盖；在东南亚市场，正积极筹备建 ...

截至发稿，利民股份市值为80亿元。 每经头条（nbdtoutiao）——天水麻辣烫、淄博烧烤、荣昌卤鹅⋯⋯"泼天流量"退去后，这些城市怎么 样了？ （记者 王晓波） 每经AI快讯，利民股份（SZ 002734，收盘价：18.03元）10月9日晚间发布业绩预告，预计2025年前三 季度归属于上市公司股东的净利润约3.84亿元~3.94亿元，同比增长649.71%~669.25%；基本每股收益 0.94元~0.97元。2025年前三季度，业绩较上年同期上升的主要原因：公司主要产品销量和价格同比上 涨、毛利率提升以及参股公司业绩上涨带来投资收益增加。 2025年1至6月份，利民股份的营业收入构成为：农药占比89.7%，兽药占比9.34%，其他业务占比 0.96%。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603609 证券简称：禾丰股份 公告编号：2025-100 债券代码：113647 债券简称：禾丰转债 禾丰食品股份有限公司 关于变更公司电子邮箱的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 禾丰食品股份有限公司（以下简称"公司"）根据实际工作需要，对公司电子邮箱进行变更，具体情况如 下： 变更前电子邮箱：hfmy@wellhope.co 变更后电子邮箱：hf@wellhopefood.com 除上述变更外，公司办公地址、联系电话等其他联系方式保持不变。变更后的电子邮箱自本公告披露之 日起正式启用，原邮箱地址同步停用，敬请广大投资者注意。由此给投资者带来的不便，敬请谅解。 特此公告。 禾丰食品股份有限公司董事会 2025年9月30日 证券代码：603609 证券简称：禾丰股份 公告编号：2025-099 债券代码：113647 债券简称：禾丰转债 禾丰食品股份有限公司 关于上海证券交易所对公司2025年半年度 报告信息披露监管问询函的回复公告 本公司董事会 ...

Core Viewpoint - The recent announcement by *ST Lvkang to "sell three wholly-owned subsidiaries for 0 yuan" has raised concerns from the Shenzhen Stock Exchange, highlighting the company's deepening operational crisis and strategic missteps [1][2]. Group 1: Asset Acquisition and Disposal - In January 2023, *ST Lvkang acquired Lvkang Yushan for 95 million yuan, viewing it as a key step into the photovoltaic film sector. However, less than two years later, this and two other subsidiaries were sold for 0 yuan to an affiliated party, Jiangxi Raoxin New Energy [2]. - The acquisition of Lvkang Yushan was based on a valuation of 95.7 million yuan, despite its book value being only 1.6035 million yuan, indicating a nearly 60-fold premium. The company claimed it had a technological advantage and stable orders as a core supplier for JinkoSolar [2]. - Following the acquisition, Lvkang Yushan reported continuous losses, with a projected loss of 203 million yuan in 2024, leading to a total book value of the three subsidiaries being negative 100 million yuan [2][3]. Group 2: Financial Performance and Strategic Failures - Originally focused on veterinary medicine, *ST Lvkang's performance declined, prompting a high-profile pivot to the photovoltaic film sector in 2023, including a 290 million yuan investment in a new production project [3]. - The company's net profit attributable to shareholders showed a downward trend with losses of 122 million yuan in 2022, 222 million yuan in 2023, and an expected 445 million yuan in 2024, totaling nearly 700 million yuan in losses [3]. - The rapid expansion in the photovoltaic sector led to oversupply, and the company failed to adapt, resulting in negative net assets and a warning of delisting risk [3]. Group 3: Related Party Transactions and Shareholder Impact - The 0 yuan transaction with Raoxin New Energy, controlled by the company's major shareholder, has been interpreted as an asset stripping maneuver to offload burdens and avoid delisting [4]. - Although the company claims that the transaction does not harm minority shareholders, the transfer of significant loss-making assets raises questions about whether it genuinely resolves underlying issues or merely conceals risks off-balance sheet [4]. Group 4: Future Challenges and Lessons - Even after shedding photovoltaic assets, *ST Lvkang faces ongoing challenges, including a shrinking core business, insufficient profitability, and tight cash flow [5]. - The company has warned of risks related to changes in its main business structure and potential underperformance in profitability following the transaction [5]. - The case of *ST Lvkang serves as a cautionary tale for companies considering cross-industry ventures, emphasizing the need for careful assessment of industry cycles and internal capabilities to avoid resource misallocation and financial crises [5].

Group 1 - The core viewpoint of the news is that Limin Co., Ltd. has shown significant stock performance with a year-to-date increase of 130.48%, despite recent declines in the last five, twenty, and sixty trading days [1][2] - As of September 26, Limin's stock price reached 17.80 yuan per share, with a market capitalization of 7.85 billion yuan and a trading volume of 1.30 billion yuan [1] - The company has a diverse revenue structure, with agricultural fungicides accounting for 50.57%, insecticides 30.51%, veterinary drugs 9.34%, herbicides 8.47%, and other products making up the remainder [1] Group 2 - Limin Co., Ltd. operates in the basic chemical industry, specifically in agricultural chemical products, and is involved in various concepts such as synthetic biology and bio-pesticides [2] - As of September 10, the number of shareholders increased to 60,300, with an average of 6,630 circulating shares per person [2] - For the first half of 2025, Limin reported a revenue of 2.45 billion yuan, reflecting a year-on-year growth of 6.69%, and a net profit of 269 million yuan, showing a substantial increase of 747.13% [2] Group 3 - Since its A-share listing, Limin has distributed a total of 919 million yuan in dividends, with 321 million yuan distributed over the past three years [3]

Core Viewpoint - *ST绿康 plans to sell three wholly-owned subsidiaries for 0 yuan, raising regulatory concerns due to the significant loss in asset value since their acquisition [1][4]. Group 1: Company Overview - *ST绿康 is a high-tech enterprise focused on the research, production, and sales of veterinary drugs, plant protection products, food additives, and photovoltaic film [1]. - The company was listed on the Shenzhen Stock Exchange in May 2017 and has been experiencing continuous losses since then [1][3]. Group 2: Asset Sale Details - The subsidiaries being sold include绿康(玉山)胶膜材料有限公司, 绿康(海宁)胶膜材料有限公司, and 绿康新能(上海)进出口贸易有限公司 [1]. - The sale price of 0 yuan is in stark contrast to the 95 million yuan paid for 绿康玉山 in January 2023, which was based on a valuation of 9570 million yuan using the income approach [2][4]. - The combined book value of the three subsidiaries has reached -1 billion yuan by the end of 2024, with 绿康玉山 alone incurring losses of 2.03 billion yuan in 2024 [3][4]. Group 3: Financial Performance - From 2022 to 2024, *ST绿康's revenue showed fluctuations: 3.30 billion yuan, 5.07 billion yuan, and 6.49 billion yuan, with net profits of -1.22 billion yuan, -2.22 billion yuan, and -4.45 billion yuan respectively [3]. - The company has faced a cumulative loss of nearly 700 million yuan over two years since entering the photovoltaic sector [3]. Group 4: Regulatory and Market Response - The transaction has drawn scrutiny from the Shenzhen Stock Exchange, which is concerned about the fairness and rationale behind the asset valuation and potential harm to shareholders [1][4]. - As of September 25, *ST绿康's stock price was 27.33 yuan per share, reflecting a decline of 2.39% and a total market capitalization of 4.248 billion yuan [5].

Group 1 - The core viewpoint of the news is that Limin Co., Ltd. has experienced a significant decline in stock price, with a drop of 5.1% on September 22, bringing the stock price to 17.67 yuan per share and a total market capitalization of 7.793 billion yuan [1] - Limin Co., Ltd. has seen a cumulative decline of 6.71% over the past three days, indicating a downward trend in its stock performance [1] - The company's main business involves the research, production, and sales of agricultural fungicides, with the revenue composition being 50.57% from agricultural fungicides, 30.51% from insecticides, 9.34% from veterinary drugs, 8.47% from herbicides, and 0.96% from other products [1] Group 2 - From the perspective of fund holdings, Southern Fund has a significant position in Limin Co., Ltd., with its Southern Strategy Optimization Mixed Fund (202019) holding 310,100 shares, representing 2.14% of the fund's net value [2] - The fund has incurred a floating loss of approximately 294,600 yuan today, with a total floating loss of 415,500 yuan during the three-day decline [2] - The Southern Strategy Optimization Mixed Fund (202019) has shown a year-to-date return of 38.54% and a one-year return of 69.32%, ranking 1809 out of 8244 and 1665 out of 8066 respectively [2]

Company Overview - Zhengbang Technology is located in Nanchang, Jiangxi Province, and was established on September 26, 1996. The company was listed on August 17, 2007. Its main business includes feed production and sales, pig breeding and sales, and veterinary drug production and sales [1][2]. - The revenue composition of Zhengbang Technology is as follows: pig farming 59.63%, complete feed 38.31%, veterinary drugs 0.92%, concentrated feed 0.62%, and others 0.52% [1]. Financial Performance - As of January to June 2025, Zhengbang Technology achieved an operating income of 6.838 billion yuan, representing a year-on-year growth of 112.17%. The net profit attributable to the parent company was 202 million yuan, with a year-on-year increase of 258.18% [2]. - Since its A-share listing, Zhengbang Technology has distributed a total of 2.864 billion yuan in dividends, with no dividends distributed in the past three years [3]. Stock Market Activity - On September 18, Zhengbang Technology's stock price decreased by 2.24%, trading at 3.06 yuan per share, with a total market capitalization of 28.305 billion yuan [1]. - The stock has seen a year-to-date increase of 4.79%, a decline of 2.24% over the last five trading days, a rise of 5.52% over the last 20 days, and a 12.09% increase over the last 60 days [1]. - As of August 20, the number of shareholders for Zhengbang Technology was 153,200, a decrease of 1.92% from the previous period, with an average of 46,699 circulating shares per person, an increase of 1.96% [2]. Industry Classification - Zhengbang Technology is classified under the Shenwan industry as part of the agriculture, forestry, animal husbandry, and fishery sector, specifically in pig farming. The company is also associated with concepts such as pork, ecological agriculture, feed, photovoltaic glass, and rural revitalization [1].

天眼查App显示，近日，丰城市天欣月贸易有限公司成立，法定代表人为袁文鹏，注册资本5万人民 币，经营范围为许可项目：兽药经营（依法须经批准的项目，经相关部门批准后在许可有效期内方可开 展经营活动，具体经营项目和许可期限以相关部门批准文件或许可证件为准）一般项目：宠物食品及用 品零售，宠物食品及用品批发，户外用品销售，服装服饰批发，服装服饰零售，园艺产品销售，体育用 品及器材批发，体育用品及器材零售，成人情趣用品销售（不含药品、医疗器械），箱包销售，汽车零 配件零售，汽车零配件批发，母婴用品销售，文具用品批发，文具用品零售，化妆品批发，化妆品零 售，工艺美术品及礼仪用品销售（象牙及其制品除外），日用杂品销售，日用品批发，家居用品销售， 美发饰品销售（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）。 ...

Group 1 - The company Zhengbang Technology (SZ 002157) held a temporary meeting of the eighth board of directors on September 15, 2025, to review the proposal for establishing the "Compensation and Assessment Committee Work Guidelines" [1] - For the first half of 2025, the revenue composition of Zhengbang Technology was as follows: breeding accounted for 59.63%, feed accounted for 38.94%, veterinary drugs accounted for 0.92%, and other businesses accounted for 0.51% [1] - As of the report date, Zhengbang Technology's market capitalization was 29.6 billion yuan [1]